Accelerating Innovation at Leica Biosystems

Running the Danaher Playbook at BEC LS RESULTS LAST 5 YEARS GROSS MARGIN G&A* S&M + R&D Annual spend ↑ >1,000BPS ~200BPS ↑ ~$100M Biomek i-Series Automated Workstation CytoFLEX S >30 CytoFLEX S Flow Cytometer NEW PRODUCT LAUNCHES LAST 3 YEARS BECKMAN COULTER Life Sciences Beckman Life Sciences Core Revenue Growth Avg. Annual +HSD/LDD +LSD OMX ↑ >1,000BPS Vi-CELL® BLU A A Cell Viability Analyzer SuperNova Fluorescent Polymer Dyes 2012-2016 2017 - 2021E * As a % of sales Balanced approach to build long-term competitive advantage DANAHER

View entire presentation